Cohen Capital Management, Inc. Heron Therapeutics, Inc. Transaction History

Cohen Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$10.23 - $24.56 $1.46 Million - $3.5 Million	-142,330 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$16.93 - $26.22 $9,311 - $14,421	550 Added 0.39%	142,330 $2.65 Million
Q4 2018 Feb 08, 2019	BUY	$22.03 - $32.01 $17,183 - $24,967	780 Added 0.55%	141,780 $3.68 Million
Q3 2018 Nov 09, 2018	BUY	$30.0 - $40.85 $8,700 - $11,846	290 Added 0.21%	141,000 $4.46 Million
Q2 2018 Jul 30, 2018	BUY	$26.4 - $42.0 $18,744 - $29,820	710 Added 0.51%	140,710 $5.47 Million
Q1 2018 May 02, 2018	BUY	$18.43 - $28.8 $2.58 Million - $4.03 Million	140,000 New	140,000 $4.42 Million

189

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $211M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Cohen Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Cohen Capital Management, Inc. with notifications on news.